Ludwig S, Zarbock A (2020) Coronaviruses and SARS-CoV-2: a brief overview. Anesthesia&amp Analgesia 131:93–96. https://doi.org/10.1213/ane.0000000000004845

Article  CAS  Google Scholar 

Xie M, Chen Q (2020) Insight into 2019 novel coronavirus– an updated interim review and lessons from SARS-CoV and MERS-CoV. Elsevier 94:119–124. https://doi.org/10.1016/j.ijid.2020.03.071

Article  CAS  Google Scholar 

World Health Organization: WHO (2023) COVID-19 vaccine tracker and landscape. World Health Organization: WHO. https://www.who.int/publications/m/item/draft-landscape-of-COVID-19-candidate-vaccines. Accessed: December 20, 2023

Malik YA (2020) Properties of coronavirus and SARS-CoV-2. Malays J Pathol 42:3–11

CAS  PubMed  Google Scholar 

Tu YF, Chien CS, Yarmishyn AA et al (2020) A review of SARS-CoV-2 and the ongoing clinical trials. Int Mol Sci 21:2657. https://doi.org/10.3390/ijms21072657

Article  CAS  Google Scholar 

Astuti I, Ysrafil (2020) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response diabetes & metabolic syndrome. Clin Res Reviews 14:407–412. https://doi.org/10.1016/j.dsx.2020.04.020

Article  Google Scholar 

Song H-D, Tu C-C, Zhang G-W et al (2005) Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci USA 102:2430–2435. https://doi.org/10.1073/pnas.0409608102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Shi Z, Yu M et al (2005) Bats are natural reservoirs of SARS-Like coronaviruses. Science 310:676–679. https://doi.org/10.1126/science.1118391

Article  CAS  PubMed  Google Scholar 

Alwine JC, Casadevall A, Enquist LW, Goodrum FD, Imperiale MJ (2023) A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses. mBio 14. https://doi.org/10.1128/mbio.00583-23

Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273. https://doi.org/10.1038/s41586-020-2012-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H-P, Sun YL, Wang YF et al (2023) Recent developments in the immunopathology of COVID-19. Allergy 78:369–388. https://doi.org/10.1111/all.15593

Article  CAS  PubMed  Google Scholar 

Fang X, Li S, Yu H et al (2020) Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging 12:12493–12503. https://doi.org/10.18632/aging.103579

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verch T, Trausch JJ, Shank-Retzlaff M (2018) Principles of vaccine potency assays. Bioanalysis 10:163–180. https://doi.org/10.4155/bio-2017-0176

Article  CAS  PubMed  Google Scholar 

Bakhiet M, Taurin S (2021) SARS-CoV-2: targeted managements and vaccine development. Cytokine &amp Growth Factor Reviews 58:16–29. https://doi.org/10.1016/j.cytogfr.2020.11.001

Article  CAS  Google Scholar 

World Health Organization: WHO (2024) WHO COVID-19 dashboard. World Health Organization: WHO. https://data.who.int/dashboards/covid19/cases?n=c. Accessed: April 26, 2024

World Health Organization: WHO (2020) Manufacturing, safety and quality control of vaccines. World Health Organization: WHO. https://www.who.int/news-room/feature-stories/detail/manufacturing-safety-and-quality-control. Accessed July 4, 2024

Beladiya J, Kumar A, Vasava Y et al (2024) Safety and efficacy of COVID-19 vaccines: a systematic review and meta‐analysis of controlled and randomized clinical trials. Rev Med Virol 34:e2507. https://doi.org/10.1002/rmv.2507

Article  CAS  PubMed  Google Scholar 

Prisma (2024) Prisma Statement. Available in: http://prisma-statement.org/PRISMAStatement/PRISMAStatement. Accessed: January 22

Prisma Flow Diagram. Available in: http://prisma-statement.org/PRISMAStatement/FlowDiagram. Accessed: 7/04/2021

Polack FP, Thomas SJ, Kitchin N et al (2021) Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 384:1576–1578. https://doi.org/10.1056/nejmc2036242

Article  CAS  Google Scholar 

Baden LR, El Sahly HM, Essink B et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384:403–416. https://doi.org/10.1056/nejmoa2035389

Article  CAS  PubMed  Google Scholar 

Voysey M, Clements SAC, Madhi SA et al (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK. Lancet 397:99–111. https://doi.org/10.1016/S0140-6736(20)32661-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanriover MD et al (2021) Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomized, placebo-controlled, phase 3 trial in Turkey. Lancet 398:213–222. https://doi.org/10.1016/S0140-6736(21)01429-X

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sadoff J et al (2021) Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19. N Engl J Med 384:2187–2201. https://doi.org/10.1056/NEJMoa2101544

Article  CAS  PubMed  Google Scholar 

Logunov DY, Dolzhikova IV, Shcheblyakov DV et al (2021) Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 397:671–681. https://doi.org/10.1016/s0140-6736(21)00234-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ella R, Reddy S, Blackwelder W et al (2021) Efficacy, Safety, and Lot to Lot Immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, Double-Blind, randomised, controlled phase 3 trial. https://doi.org/10.1101/2021.06.30.21259439. Cold Spring Harbor Laboratory

Heath PT, Galiza EP, Baxter DN et al (2021) Safety and efficacy of NVX-CoV2373 COVID-19 vaccine. N Engl J Med 385:1172–1183. https://doi.org/10.1056/NEJMoa2107659

Article  CAS  PubMed  Google Scholar 

Kaabi NA et al (2021) Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a Randomized Clinical Trial. JAMA 326:35–45. https://doi.org/10.1001/jama.2021.8565

Article  CAS  PubMed  Google Scholar 

Charland N, Gobeil P, Pillet S et al (2022) Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in adults with and without comorbidities. npj Vaccines 7:142. https://doi.org/10.1038/s41541-022-00561-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halperin SA, Ye L, MacKinnon-Cameron D et al (2022) Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial. Lancet 399:237–248. https://doi.org/10.1016/s0140-6736(21)02753-7

Article  CAS  PubMed  Google Scholar 

Li JX, Zhu FC (2021) Adjuvantation helps to optimise COVID-19 vaccine candidate. Lancet Infect Dis 21:891–893. https://doi.org/10.1016/s1473-3099(21)00094-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palacios R, Patiño EG, de Oliveira Piorelli R et al (2020) Double-Blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating Healthcare Professionals with the Adsorbed COVID-19 (inactivated) vaccine manufactured by sinovac– PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials 21. https://doi.org/10.1186/s13063-020-04775-4

Article  Google Scholar 

Hager KJ, Pérez Marc G, Gobeil P et al (2022) Efficacy and safety of a recombinant plant-based adjuvanted COVID-19 vaccine. N Engl J Med 386:2084–2096. https://doi.org/10.1056/nejmoa2201300

Article  CAS  PubMed  Google Scholar 

Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ (2021) What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis 21:e26–e35. https://doi.org/10.1016/s1473-3099(20)30773-8

Article  CAS